ASX 200 lunch update: Clinuvel & Resolute higher, CBA lower

Clinuvel Pharmaceuticals Limited (ASX:CUV), Commonwealth Bank of Australia (ASX: CBA), and Resolute Mining Limited (ASX:RSG) are making waves on the ASX 200 on Monday…

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 index has started the week on a disappointing note. At lunch the benchmark index is down 0.5% to 6,896.6 points.

Here's what has been happening on the market today:

Bank shares mixed.  

Australia's big four banks are trading mixed on Monday. One of the four is trading higher and three are trading lower at lunch time. The best performer in the group is the National Australia Bank Ltd (ASX: NAB) share price with a 0.2% gain. Whereas the Commonwealth Bank of Australia (ASX: CBA) share price is the worst performer with a 0.2% decline.

Gold miners push higher.

Gold miners such as Resolute Mining Limited (ASX: RSG) and St Barbara Ltd (ASX: SBM) are pushing higher on Monday after the gold price rose on Friday. According to CNBC, the spot gold price pushed 0.4% higher to US$1,560.10 an ounce after weakness on Wall Street following the release of December's U.S. jobs data. At lunch the S&P/ASX All Ords Gold index is up 0.7%.

Clinuvel rated as a buy.

The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price is storming higher on Monday after being the subject of a bullish broker note. Moelis Australia has placed a buy rating and $44.42 price target on the biopharmaceutical company's shares. It appears confident that its SCENESSE product will drive strong profit growth over the coming years.

Best and worst performers.

The best performer on the ASX 200 at lunch is the Clinuvel share price with a gain of 3.5%. Moelis Australia's positive broker note appears to be behind the rampant buying. Going the other way is the Virgin Money UK PLC (ASX: VUK) share price with a 3.5% decline on no news. This latest decline means the UK-based bank's shares have fallen over 17% since December 16. This may be down to profit taking after very strong gains in 2019.  

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of National Australia Bank Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »